X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SHASUN PHARMA with Abbott India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHASUN PHARMA vs ABBOTT INDIA - Comparison Results

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SHASUN PHARMA ABBOTT INDIA SHASUN PHARMA/
ABBOTT INDIA
 
P/E (TTM) x 123.9 39.4 314.9% View Chart
P/BV x 8.5 11.4 75.0% View Chart
Dividend Yield % 0.2 0.5 43.3%  

Financials

 SHASUN PHARMA   ABBOTT INDIA
EQUITY SHARE DATA
    SHASUN PHARMA
Mar-14
ABBOTT INDIA
Mar-17
SHASUN PHARMA/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs945,190 1.8%   
Low Rs464,351 1.0%   
Sales per share (Unadj.) Rs214.21,382.9 15.5%  
Earnings per share (Unadj.) Rs5.3130.2 4.1%  
Cash flow per share (Unadj.) Rs15.8137.9 11.5%  
Dividends per share (Unadj.) Rs1.0040.00 2.5%  
Dividend yield (eoy) %1.40.8 170.6%  
Book value per share (Unadj.) Rs53.3652.7 8.2%  
Shares outstanding (eoy) m56.6221.25 266.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.33.4 9.5%   
Avg P/E ratio x13.136.6 35.7%  
P/CF ratio (eoy) x4.434.6 12.8%  
Price / Book Value ratio x1.37.3 17.9%  
Dividend payout %18.730.7 61.0%   
Avg Mkt Cap Rs m3,958101,373 3.9%   
No. of employees `000NA3.1 0.0%   
Total wages/salary Rs m2,1643,453 62.7%   
Avg. sales/employee Rs ThNM9,531.9-  
Avg. wages/employee Rs ThNM1,119.9-  
Avg. net profit/employee Rs ThNM897.3-  
INCOME DATA
Net Sales Rs m12,12729,387 41.3%  
Other income Rs m229576 39.8%   
Total revenues Rs m12,35629,963 41.2%   
Gross profit Rs m1,0093,973 25.4%  
Depreciation Rs m594164 361.3%   
Interest Rs m41520 2,034.8%   
Profit before tax Rs m2304,365 5.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-731,598 -4.5%   
Profit after tax Rs m3022,767 10.9%  
Gross profit margin %8.313.5 61.5%  
Effective tax rate %-31.736.6 -86.5%   
Net profit margin %2.59.4 26.5%  
BALANCE SHEET DATA
Current assets Rs m6,88418,906 36.4%   
Current liabilities Rs m8,4566,297 134.3%   
Net working cap to sales %-13.042.9 -30.2%  
Current ratio x0.83.0 27.1%  
Inventory Days Days6262 99.1%  
Debtors Days Days10822 497.0%  
Net fixed assets Rs m4,9701,159 428.9%   
Share capital Rs m113213 53.3%   
"Free" reserves Rs m2,87513,657 21.1%   
Net worth Rs m3,02013,869 21.8%   
Long term debt Rs m1,8170-   
Total assets Rs m13,34720,638 64.7%  
Interest coverage x1.6215.0 0.7%   
Debt to equity ratio x0.60-  
Sales to assets ratio x0.91.4 63.8%   
Return on assets %5.413.5 39.8%  
Return on equity %10.019.9 50.1%  
Return on capital %13.331.6 42.1%  
Exports to sales %46.40-   
Imports to sales %14.20-   
Exports (fob) Rs m5,622NA-   
Imports (cif) Rs m1,728NA-   
Fx inflow Rs m5,8430-   
Fx outflow Rs m2,1730-   
Net fx Rs m3,6690-   
CASH FLOW
From Operations Rs m3983,072 12.9%  
From Investments Rs m-1,635-1,554 105.2%  
From Financial Activity Rs m1,309-898 -145.8%  
Net Cashflow Rs m71621 11.5%  

Share Holding

Indian Promoters % 39.2 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 3.6 7.9 45.6%  
FIIs % 17.6 0.1 17,600.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.6 17.1 231.6%  
Shareholders   20,750 18,270 113.6%  
Pledged promoter(s) holding % 12.3 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SHASUN PHARMA With:   DISHMAN PHARMA  ELDER PHARMA  SUVEN LIFE  PANACEA BIOTECH  WOCKHARDT LTD.  

Compare SHASUN PHARMA With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Day up 260 Points; Pharma Stocks Top Gainers(Closing)

After opening the day in red, share markets in India witnessed positive trading activity throughout the day and ended the day on a positive note.

Related Views on News

ABBOTT INDIA at All Time High; BSE HEALTHCARE Index Down 0.7%

Jun 22, 2018 | Updated on Jun 22, 2018

ABBOTT INDIA share price has hit an all time high at Rs 7,420 (up 1.67%). The BSE HEALTHCARE Index is down by 0.74%. Among the top gainers in the BSE HEALTHCARE Index today are ABBOTT INDIA (up 1.67%) and GSK PHARMA (up 0.01%). The top losers include PFIZER (down 0.00%) and IPCA LABS (down 0.01%).

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

Will You Dump Your Client if You're Busy? Inox Wind's Auditor Just Did...(The 5 Minute Wrapup)

Jun 14, 2018

After Inox Wind, you may see more auditors resigning And the reasons can be as funny as they can get.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Should You Invest In Mirae Asset Healthcare Fund?(Outside View)

Jun 15, 2018

Mirae Asset Mutual Fund launches NFO - Mirae Asset Helathcare Fund.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SHASUN PHARMA SHARE PRICE


Nov 17, 2015 (Close)

TRACK SHASUN PHARMA

  • Track your investment in SHASUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SHASUN PHARMA 8-QTR ANALYSIS

COMPARE SHASUN PHARMA WITH

MARKET STATS